Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 339943

Страница 1 из 33995

Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts
Kobalava J.D., Gurevich V.S., Galyavich A.M., Kaminnyi A.I., Kashtalap V.V., Mareev V.Y., Susekov A.V., Shaposhnik I.I.
bioequivalence to the original drug Ezetrol tablets 10 mg (Schering-plough Labo N. V,Belgium). Broad use of a new
Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)
Oganov R.G., Kukharchuk V.V., Arutyunov G.P., Galyavich A.S., Gurevich V.S., Duplyakov D.V., KarpovYu A., Konstantinov V.O., Yu M.S., Panov A.V., Sergienko I.V., Skibitskyi V.V., Smolenskaya O.G., Susekov A.V., Tyurin V.P., Shalaev S.V., Maneshina O.A., Brigida O.V., Kobalava Zh D.
,4% in moderate-risk patients (<3,0 mol/l). Conclusion. Over a half of the statin-treated patients failed
FIVE YEAR EXPERIENCE OF INTENSIVE LIPID-LOWERING TREATMENT OF 14 YEARS OLD BOY WITH HOMOZYGOUS FAMILAIL HYPERCHOLESTEROLEMIA: A CASE REPORT
SUSEKOV, A., SOLOVYEV, V., LEONTYEVA, I., ZAFIRAKI, V., IAKOVLEVA, L.
prognosis due to fast progression of CVD. We report a case of 14 years old boy with homoFH treated
FIVE YEAR EXPERIENCE OF INTENSIVE LIPID-LOWERING TREATMENT OF 14 YEARS OLD BOY WITH HOMOZYGOUS FAMILAIL HYPERCHOLESTEROLEMIA: A CASE REPORT
SUSEKOV, A., SOLOVYEV, V., LEONTYEVA, I., ZAFIRAKI, V., IAKOVLEVA, L.
prognosis due to fast progression of CVD. We report a case of 14 years old boy with homoFH treated
COMPLETE REGRESSION OF XANTHOMATA IN 2 YEARS OLD GIRL WITH HOMOZYGOUS BETA-SITOSTEROLEMIA TREATED WITH EZETIMIBE 5 MG/DAY
SUSEKOV, A., SOLOVYEV, V., LEONTYEVA, I., SONICHEVA, N., GUISTINIANI, D.G., ZAFIRAKI, V., YAKOVLEVA, L.V.
Beta-sitosterolemia (BS) is a rare autosomal-recessive monogenic lipid disorder, with elevation
COMPLETE REGRESSION OF XANTHOMATA IN 2 YEARS OLD GIRL WITH HOMOZYGOUS BETA-SITOSTEROLEMIA TREATED WITH EZETIMIBE 5 MG/DAY
SUSEKOV, A., SOLOVYEV, V., LEONTYEVA, I., SONICHEVA, N., GUISTINIANI, D.G., ZAFIRAKI, V., YAKOVLEVA, L.V.
Beta-sitosterolemia (BS) is a rare autosomal-recessive monogenic lipid disorder, with elevation
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report
Grundy S.M.
An international panel of the International Atherosclerosis Society has developed a new set
Possibilities of clinical use of ezetimibe Otrio (JSC “AKRIKHIN”, Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts
Kobalava J.D., Gurevich V.S., Galyavich A.M., Kaminnyi A.I., Kashtalap V.V., Mareev V.Y., Susekov A.V., Shaposhnik I.I.
bioequivalence to the original drug Ezetrol tablets 10 mg (Schering-plough Labo N. V,Belgium). Broad use of a new
Enets Language in the Studies of Domestic and Foreign Scientists
Kolesnik, Maria A., Libakova, Natalia M., Sertakova, Ekaterina A., Колесник, М.А., Либакова, Н.М., Сертакова, Е.А.
The article presents a historiographical review of foreign and domestic research literature devoted
Current rabies epizootiology
Makarov V.V., Dzhupina S.I., Vedernikov V.A., Zavodskikh A.V., Afonin V.N., Baldina I.V.

Страница 1 из 33995

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core